Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • ICG–MXene/Bletilla Hydrogel: Synergistic Antibacterial and W

    2026-05-28

    ICG–MXene/Bletilla Hydrogel: Synergistic Antibacterial and Wound Healing Innovation

    Study Background and Research Question

    Effective wound healing requires not only the restoration of the skin’s structural integrity but also the management of microbial infections that commonly complicate the repair process. Chronic wounds, particularly those colonized by bacteria such as Staphylococcus aureus, pose significant clinical challenges due to delayed healing and rising antibiotic resistance. Conventional wound dressings often fall short in providing active antimicrobial action or supporting the complex biological processes underlying tissue regeneration. As highlighted in the reference study, the need for advanced materials that simultaneously address infection, inflammation, and tissue regeneration has driven the search for multifunctional wound dressings.

    Key Innovation from the Reference Study

    The study presents a nanocomposite hydrogel that leverages the synergistic potential of photothermal therapy (PTT) and photodynamic therapy (PDT) by integrating indocyanine green (ICG)-loaded Ti3C2Tx MXene nanosheets into a Bletilla striata polysaccharide (BSP) hydrogel matrix. This design allows the hydrogel to perform dual antibacterial functions upon near-infrared (NIR) light irradiation, while BSP contributes to tissue compatibility and healing. The innovation lies in the combination of two-dimensional MXene’s photothermal/photoactive properties, ICG’s photosensitizing capacity, and BSP’s pro-regenerative effects in a single, biocompatible hydrogel platform.

    Methods and Experimental Design Insights

    To develop the hydrogel, the researchers embedded ICG-loaded MXene nanosheets within a BSP-doped hydrogel. The hydrogel’s physical, adhesive, and biocompatibility properties were characterized through swelling studies, tensile strength measurements, and cytocompatibility assays. The antibacterial efficacy was tested against S. aureus under 808 nm NIR light to simulate clinical phototherapeutic conditions. Additionally, in vivo wound healing models were employed to assess collagen deposition, angiogenesis, and re-epithelialization over a 14-day period.

    • The swelling rate and adhesive strength quantified the hydrogel’s ability to maintain a moist environment and adhere to wound sites.
    • Antibacterial activity was evaluated by measuring bacterial survival post-irradiation, ensuring that both PTT and PDT mechanisms were activated in situ.
    • Histological assessment enabled quantification of collagen content and epidermal thickness, correlating these with functional wound closure outcomes.

    Protocol Parameters

    • ICG loading: Indocyanine green was incorporated onto MXene nanosheets prior to hydrogel embedding.
    • BSP content: BSP was doped into the hydrogel matrix to enhance biocompatibility and regenerative effects.
    • Phototherapy regimen: 808 nm NIR light was applied to activate both photothermal and photodynamic effects during antibacterial assays and in vivo treatment.
    • Assessment timeline: Wound closure and tissue regeneration were monitored over a 14-day period in animal models.

    Core Findings and Why They Matter

    The hydrogel demonstrated a swelling rate of 485.53% ± 0.26% after 48 hours and an adhesive strength of 629 KPa ± 15.52 KPa, surpassing many conventional dressings (reference study). Its biocompatibility was confirmed through cytocompatibility testing. Most notably, the hydrogel achieved over 90% antibacterial activity against S. aureus after NIR irradiation, reflecting the efficacy of combined PTT and PDT mechanisms.

    In vivo, the hydrogel promoted rapid wound closure (98% after 14 days), high collagen deposition (87.63% ± 1.81%), and substantial epidermal regeneration (epidermis thickness 130.33 μm ± 1.25 μm). These metrics are indicative of improved tissue remodeling and angiogenesis, key processes in effective wound healing. The integration of BSP, a traditional Chinese medicinal polysaccharide, supports cell proliferation and differentiation, aligning with findings from serine protease applications in wound repair and inflammation modulation.

    Comparison with Existing Internal Articles

    The mechanisms by which the nanocomposite hydrogel accelerates wound healing can be related to established roles of serine proteases like trypsin in tissue repair and inflammation. Internal resources such as "Trypsin’s Mechanistic Leverage: Translational Advances in Protease Biology" emphasize the importance of precise proteolytic signaling in cell proliferation and matrix remodeling. Additionally, "Trypsin: The Essential Serine Protease for Advanced Cell..." details trypsin’s utility in workflows ranging from cell culture to wound healing research, highlighting parallels in the need for reliable, biocompatible reagents that facilitate tissue regeneration without exacerbating inflammation or infection.

    While the hydrogel leverages phototherapy for antibacterial action, both approaches converge on the principle of supporting endogenous healing processes while mitigating microbial interference. Furthermore, the use of BSP in the hydrogel complements the pro-healing effects attributed to serine proteases, reinforcing the trend toward multifunctional, bioactive wound management tools.

    Limitations and Transferability

    Despite its promising performance, the hydrogel’s efficacy is currently demonstrated against a model pathogen (S. aureus) and in animal wound models. Clinical translation will require validation against a broader spectrum of pathogens, including antibiotic-resistant strains, and assessment of long-term safety, degradation, and host response in human subjects. The need for external NIR irradiation equipment may also limit immediate bedside adoption, although portable phototherapeutic devices are increasingly available.

    Transferability to chronic or complex wounds, and to patient populations with impaired healing (e.g., diabetics), remains to be explored. Additionally, while BSP and ICG are biocompatible, the stability and potential immunogenicity of MXene-based materials require further study before widespread clinical application.

    Research Support Resources

    For laboratories seeking to replicate or extend findings in wound healing research, the choice of proteolytic enzymes for cell culture, matrix remodeling, or inflammation studies is critical. Trypsin (SKU BA5744) from APExBIO offers robust solubility and specificity as a serine protease hydrolyzing lysine and arginine residues, facilitating workflows in cell proliferation, differentiation, and tissue engineering. Its proven performance supports experimental reproducibility in both basic and translational research, as discussed in related internal reviews. Researchers interested in integrating protease-mediated cell handling or matrix digestion with advanced biomaterials may consider such reagents to optimize regenerative and antibacterial experimental protocols.